Publication Information

{'id': 'https://openalex.org/W2361796690', 'doi': None, 'title': 'Clinical Efficacy of Changyanning Capsule Combined with Mesalazine in the Treatment of Ulcerative Colitis', 'display_name': 'Clinical Efficacy of Changyanning Capsule Combined with Mesalazine in the Treatment of Ulcerative Colitis', 'publication_year': 2014, 'publication_date': '2014-01-01', 'ids': {'openalex': 'https://openalex.org/W2361796690', 'mag': '2361796690'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZYXB201404053.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764752220', 'display_name': 'Zhongyi-yao xuebao', 'issn_l': '1002-2392', 'issn': ['1002-2392'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5044426459', 'display_name': 'Hongjin Liu', 'orcid': 'https://orcid.org/0000-0001-5625-2395'}, 'institutions': [{'id': 'https://openalex.org/I4210096351', 'display_name': 'Qinhuangdao Second Hospital', 'ror': 'https://ror.org/00rcpde19', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210096351']}], 'countries': ['CN'], 'is_corresponding': True, 'raw_author_name': 'Liu Hong-jin', 'raw_affiliation_strings': ['Qinhuangdao Harbor Hospital'], 'affiliations': [{'raw_affiliation_string': 'Qinhuangdao Harbor Hospital', 'institution_ids': ['https://openalex.org/I4210096351']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5044426459'], 'corresponding_institution_ids': ['https://openalex.org/I4210096351'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.553662, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 66, 'max': 73}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12817', 'display_name': 'Pharmacological Effects of Natural Compounds', 'score': 0.9812, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12817', 'display_name': 'Pharmacological Effects of Natural Compounds', 'score': 0.9812, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10134', 'display_name': 'Inflammatory Bowel Disease', 'score': 0.9399, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T14331', 'display_name': 'Medicinal Plant Pharmacodynamics Research', 'score': 0.9199, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/mesalazine', 'display_name': 'Mesalazine', 'score': 0.98123056}, {'id': 'https://openalex.org/keywords/capsule', 'display_name': 'Capsule', 'score': 0.66603684}, {'id': 'https://openalex.org/keywords/clinical-efficacy', 'display_name': 'Clinical efficacy', 'score': 0.5430829}], 'concepts': [{'id': 'https://openalex.org/C2779174533', 'wikidata': 'https://www.wikidata.org/wiki/Q412479', 'display_name': 'Mesalazine', 'level': 4, 'score': 0.98123056}, {'id': 'https://openalex.org/C2780479503', 'wikidata': 'https://www.wikidata.org/wiki/Q1477', 'display_name': 'Ulcerative colitis', 'level': 3, 'score': 0.859123}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8375541}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.7952059}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.7310835}, {'id': 'https://openalex.org/C2778778583', 'wikidata': 'https://www.wikidata.org/wiki/Q147768', 'display_name': 'Capsule', 'level': 2, 'score': 0.66603684}, {'id': 'https://openalex.org/C2992053201', 'wikidata': 'https://www.wikidata.org/wiki/Q2585693', 'display_name': 'Clinical efficacy', 'level': 2, 'score': 0.5430829}, {'id': 'https://openalex.org/C61511704', 'wikidata': 'https://www.wikidata.org/wiki/Q1671857', 'display_name': 'Incidence (geometry)', 'level': 2, 'score': 0.48636606}, {'id': 'https://openalex.org/C2775862500', 'wikidata': 'https://www.wikidata.org/wiki/Q2453464', 'display_name': 'Colitis', 'level': 2, 'score': 0.43873566}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.43098724}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.14298677}, {'id': 'https://openalex.org/C59822182', 'wikidata': 'https://www.wikidata.org/wiki/Q441', 'display_name': 'Botany', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C121332964', 'wikidata': 'https://www.wikidata.org/wiki/Q413', 'display_name': 'Physics', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C120665830', 'wikidata': 'https://www.wikidata.org/wiki/Q14620', 'display_name': 'Optics', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZYXB201404053.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764752220', 'display_name': 'Zhongyi-yao xuebao', 'issn_l': '1002-2392', 'issn': ['1002-2392'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.83, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3030304332', 'https://openalex.org/W3029664240', 'https://openalex.org/W2394173950', 'https://openalex.org/W2392725485', 'https://openalex.org/W2392438402', 'https://openalex.org/W2386755131', 'https://openalex.org/W2386497540', 'https://openalex.org/W2385800859', 'https://openalex.org/W2384400821', 'https://openalex.org/W2377486882', 'https://openalex.org/W2377263371', 'https://openalex.org/W2377180302', 'https://openalex.org/W2376886101', 'https://openalex.org/W2372133875', 'https://openalex.org/W2361777468', 'https://openalex.org/W2361556633', 'https://openalex.org/W2355129079', 'https://openalex.org/W2352254143', 'https://openalex.org/W2350497213', 'https://openalex.org/W2350089982'], 'abstract_inverted_index': {'Objective:': [0], 'To': [1], 'evaluate': [2], 'the': [3, 13, 35, 56, 67, 114, 122, 125, 134, 137, 150, 159, 163, 171, 177, 203], 'clinical': [4, 82, 160, 194, 216], 'efficacy': [5, 161, 195], 'of': [6, 15, 162, 179, 196, 205, 215], 'Changyanning': [7, 61, 197], 'capsule': [8, 198], 'combined': [9, 199], 'with': [10, 21, 63, 200], 'mesalazine': [11, 64, 74, 201], 'in': [12, 30, 55, 66, 84, 103, 113, 121, 149, 170, 182, 202], 'treatment': [14, 43, 57, 91, 115, 135, 164, 204], 'ulcerative': [16, 22, 206], 'colitis.': [17], 'Methods:': [18], '89': [19], 'patients': [20, 54], 'colitis': [23, 207], 'from': [24], 'January': [25], '2010': [26], 'to': [27, 50, 168], 'September': [28], '2013': [29], 'our': [31], 'hospital': [32], 'were': [33, 38, 59, 72, 87, 100, 117, 127], 'for': [34, 92], 'study,and': [36], 'they': [37], 'randomly': [39], 'divided': [40], 'into': [41], 'a': [42, 46], 'group': [44, 48, 58, 69, 116, 136, 165], 'and': [45, 81], 'control': [47, 68, 123, 151, 172], 'according': [49], 'visiting': [51], 'sequence.': [52], '45': [53], 'given': [60, 73], 'capsules': [62], 'treatment,and': [65], '44': [70], 'cases': [71], 'treatment.': [75], 'Serum': [76], 'IL-': [77, 96, 109], '1,IL-': [78, 97, 110], '8,TNF-': [79, 98, 111], 'α,Fib,MPV': [80, 99, 112], 'outcomes': [83], 'both': [85, 104], 'groups': [86, 184], 'compared.': [88], 'Results:': [89], 'After': [90], '30': [93], 'd,the': [94], 'serum': [95], 'significantly': [101], 'decreased': [102], 'groups(': [105], 'P': [106, 130, 174, 189], '0.': [107, 131, 175, 190], '05),but': [108], 'lower': [118], 'than': [119, 146, 210], 'those': [120], 'group,and': [124], 'differences': [126], 'statistically': [128], 'significant(': [129], '05).': [132, 191], 'In': [133], 'total': [138], 'effective': [139], 'rate': [140], 'was': [141, 144, 166], '95.': [142], '6%,which': [143], 'higher': [145], '81.': [147], '8%': [148], 'group.': [152], 'Mann-': [153], 'Whitney': [154], 'U': [155], 'test': [156], 'showed': [157], 'that': [158, 169], 'superior': [167], 'group(': [173], '05),and': [176], 'incidence': [178], 'adverse': [180], 'events': [181], 'two': [183], 'had': [185], 'no': [186], 'significant': [187], 'difference(': [188], 'Conclusion:': [192], 'The': [193], 'is': [208, 213], 'better': [209], 'single': [211], 'mesalazine,which': [212], 'worthy': [214], 'application.': [217]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2361796690', 'counts_by_year': [{'year': 2021, 'cited_by_count': 1}], 'updated_date': '2024-12-14T16:40:44.457664', 'created_date': '2016-06-24'}